CFB
AZN icon

Cullen/Frost Bankers’s AstraZeneca AZN Stock Holding History

Cullen/Frost Bankers’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.1M Buy
84,701
+4,991
+6% +$939K 0.16% 127
2026
Q1 		$15.7M Buy
79,710
+202
+0.3% +$38.9K 0.18% 118
2025
Q4 		$14.6M Sell
79,508
-173
-0.2% -$30.3K 0.16% 126
2025
Q3 		$12.2M Sell
79,681
-1,947
-2% -$295K 0.14% 140
2025
Q2 		$11.4M Sell
81,628
-611
-0.7% -$85.6K 0.14% 143
2025
Q1 		$12.1M Sell
82,239
-97
-0.1% -$14K 0.17% 130
2024
Q4 		$10.8M Buy
82,336
+5,936
+8% +$831K 0.15% 139
2024
Q3 		$11.9M Sell
76,400
-2,966
-4% -$479K 0.16% 132
2024
Q2 		$12.4M Sell
79,366
-2,556
-3% -$385K 0.18% 125
2024
Q1 		$11.1M Sell
81,922
-1,452
-2% -$192K 0.16% 141
2023
Q4 		$11.2M Sell
83,374
-817
-1% -$106K 0.18% 138
2023
Q3 		$11.4M Sell
84,191
-2,315
-3% -$316K 0.2% 122
2023
Q2 		$12.4M Sell
86,506
-3,576
-4% -$526K 0.21% 118
2023
Q1 		$12.5M Sell
90,082
-2,363
-3% -$318K 0.23% 112
2022
Q4 		$12.5M Buy
92,445
+41,118
+80% +$5.16M 0.24% 114
2022
Q3 		$5.63M Buy
51,327
+2,396
+5% +$304K 0.13% 159
2022
Q2 		$6.47M Buy
48,931
+2,598
+6% +$341K 0.15% 151
2022
Q1 		$6.15M Sell
46,333
-40
-0.1% -$4.8K 0.12% 167
2021
Q4 		$5.4M Sell
46,373
-3,663
-7% -$431K 0.1% 180
2021
Q3 		$6.01M Sell
50,036
-21,537
-30% -$2.51M 0.12% 168
2021
Q2 		$8.57M Sell
71,573
-20,412
-22% -$2.24M 0.17% 129
2021
Q1 		$9.15M Sell
91,985
-22,435
-20% -$2.26M 0.2% 122
2020
Q4 		$11.4M Buy
114,420
+3,186
+3% +$337K 0.26% 98
2020
Q3 		$12.2M Sell
111,234
-2,926
-3% -$325K 0.3% 90
2020
Q2 		$12.1M Sell
114,160
-451
-0.4% -$46.6K 0.32% 88
2020
Q1 		$10.2M Sell
114,611
-2,207
-2% -$208K 0.36% 82
2019
Q4 		$11.6M Sell
116,818
-23,680
-17% -$2.23M 0.32% 95
2019
Q3 		$12.5M Buy
140,498
+27,244
+24% +$2.36M 0.37% 83
2019
Q2 		$9.35M Buy
113,254
+110,011
+3,392% +$8.63M 0.29% 103
2019
Q1 		$262K Sell
3,243
-855
-21% -$67.4K 0.01% 361
2018
Q4 		$311K Sell
4,098
-455
-10% -$35.5K 0.01% 328
2018
Q3 		$360K Sell
4,553
-10
-0.2% -$756 0.01% 325
2018
Q2 		$321K Sell
4,563
-149
-3% -$10.7K 0.01% 338
2018
Q1 		$330K Buy
+4,712
New +$326K 0.01% 339

Other funds holding AZN

EPGL
Evelyn Partners Group Ltd London $46.9B AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Cullen/Frost Bankers's AZN Position: Q2 2026 in Review

Cullen/Frost Bankers increased its AstraZeneca (AZN) stake by 6.3% in Q2 2026, buying an estimated $939K and bringing the position to 84,701 shares worth $16.1M. The position accounts for 0.16% of the portfolio, ranked #127.

Cullen/Frost Bankers first reported a position in AZN in Q1 2018 and has held it in 34 quarters since. 906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Cullen/Frost Bankers held 84,701 shares of AstraZeneca worth $16.1M as of Q2 2026.
  • Cullen/Frost Bankers bought 4,991 AstraZeneca shares in Q2 2026, an estimated $939K.
  • AstraZeneca made up 0.16% of Cullen/Frost Bankers's portfolio in Q2 2026, its #127 holding.
  • Cullen/Frost Bankers first reported a position in AstraZeneca in Q1 2018 and has held it in 34 quarters since.
  • 906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.